List of Plenvu drug patents

Plenvu is owned by Salix.

Plenvu contains Ascorbic Acid; Polyethylene Glycol 3350; Potassium Chloride; Sodium Ascorbate; Sodium Chloride; Sodium Sulfate.

Plenvu has a total of 10 drug patents out of which 0 drug patents have expired.

Plenvu was authorised for market use on 04 May, 2018.

Plenvu is available in for solution;oral dosage forms.

Plenvu can be used as for cleansing of the colon in preparation for colonoscopy in adults.

The generics of Plenvu are possible to be released after 10 September, 2033.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10792306 SALIX Colonoscopy—preparation
Mar, 2032

(9 years from now)

US10780112 SALIX Colonoscopy-preparation
Mar, 2032

(9 years from now)

US11529368 SALIX Colonoscopy—preparation
Mar, 2032

(9 years from now)

US10646512 SALIX Colonoscopy - preparation
Mar, 2032

(9 years from now)

US9592252 SALIX Colonoscopy—preparation
Aug, 2032

(9 years from now)

US10016504 SALIX Compositions
Sep, 2033

(10 years from now)

US10918723 SALIX Colon cleansing compositions and methods of use
Sep, 2033

(10 years from now)

US9707297 SALIX Compositions
Sep, 2033

(10 years from now)

US9326969 SALIX Compositions
Sep, 2033

(10 years from now)

US8999313 SALIX Compositions
Sep, 2033

(10 years from now)

Drugs and Companies using ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE ingredient

Market Authorisation Date: 04 May, 2018

Treatment: For cleansing of the colon in preparation for colonoscopy in adults

Dosage: FOR SOLUTION;ORAL

How can I launch a generic of PLENVU before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in